Estrella Immunopharma, Inc. (ESLA)
NASDAQ: ESLA · Real-Time Price · USD
1.552
+0.022 (1.46%)
Apr 29, 2026, 11:46 AM EDT - Market open
Estrella Immunopharma Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2024 | FY 2023 | FY 2022 | 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | 2021 |
| Cash & Equivalents | 1.38 | 0.92 | 4.17 | 2.48 | 4.09 | Upgrade
|
| Cash & Short-Term Investments | 1.38 | 0.92 | 4.17 | 2.48 | 4.09 | Upgrade
|
| Cash Growth | 50.97% | -77.99% | 68.02% | -39.36% | - | Upgrade
|
| Receivables | - | - | - | 0.27 | - | Upgrade
|
| Prepaid Expenses | 0.29 | 0.72 | 0.29 | - | 0.83 | Upgrade
|
| Total Current Assets | 1.68 | 1.64 | 4.45 | 2.75 | 4.92 | Upgrade
|
| Long-Term Deferred Charges | - | - | - | 0.28 | - | Upgrade
|
| Other Long-Term Assets | 1.5 | 1.5 | - | - | - | Upgrade
|
| Total Assets | 3.18 | 3.14 | 4.45 | 3.03 | 4.92 | Upgrade
|
| Accounts Payable | 0.55 | 0 | - | - | - | Upgrade
|
| Accrued Expenses | 12.61 | 2.98 | 0.14 | 8.85 | 0.03 | Upgrade
|
| Current Portion of Leases | 0.01 | 0 | 0 | 0.02 | - | Upgrade
|
| Current Income Taxes Payable | - | 0 | 0.04 | - | - | Upgrade
|
| Other Current Liabilities | 0.38 | 0.01 | 0 | 0.88 | 0.92 | Upgrade
|
| Total Current Liabilities | 13.54 | 3 | 0.18 | 9.76 | 0.95 | Upgrade
|
| Other Long-Term Liabilities | - | - | - | 0.01 | 0.01 | Upgrade
|
| Total Liabilities | 13.54 | 3 | 0.18 | 9.77 | 0.96 | Upgrade
|
| Common Stock | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 27.22 | 24.64 | 24.12 | 0.45 | 0.03 | Upgrade
|
| Retained Earnings | -36.99 | -23.93 | -19.5 | -12.19 | -1.07 | Upgrade
|
| Treasury Stock | -0.6 | -0.57 | -0.35 | - | - | Upgrade
|
| Total Common Equity | -10.37 | 0.14 | 4.27 | -11.74 | -1.04 | Upgrade
|
| Shareholders' Equity | -10.37 | 0.14 | 4.27 | -6.74 | 3.96 | Upgrade
|
| Total Liabilities & Equity | 3.18 | 3.14 | 4.45 | 3.03 | 4.92 | Upgrade
|
| Total Debt | 0.01 | 0 | 0 | 0.02 | - | Upgrade
|
| Net Cash (Debt) | 1.38 | 0.91 | 4.16 | 2.46 | 4.09 | Upgrade
|
| Net Cash Growth | 50.98% | -78.06% | 69.36% | -39.90% | - | Upgrade
|
| Net Cash Per Share | 0.04 | 0.03 | 0.15 | 8.04 | - | Upgrade
|
| Filing Date Shares Outstanding | 42.67 | 36.17 | 36.19 | 35.2 | 0.18 | Upgrade
|
| Total Common Shares Outstanding | 37.97 | 36.19 | 36.29 | 4.06 | 0.18 | Upgrade
|
| Working Capital | -11.87 | -1.36 | 4.27 | -7.01 | 3.97 | Upgrade
|
| Book Value Per Share | -0.27 | 0.00 | 0.12 | -2.89 | -5.91 | Upgrade
|
| Tangible Book Value | -10.37 | 0.14 | 4.27 | -11.74 | -1.04 | Upgrade
|
| Tangible Book Value Per Share | -0.27 | 0.00 | 0.12 | -2.89 | -5.91 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.